We report a method for effectively and homogeneously incorporating carbon nanotubes (CNTs) in the form of double-wall (DWCNTs) and multi-wall (MWCNTs) structures into commercial paints without the use of additives, surfactants, or chemical processes. The process involves the physical mixing of the nanotubes and polymers using the cavitation energy of an ultrasonic bath. It is a simple, fast method that allows for uniform distribution of carbon nanotube bundles within the polymer for direct application. Due to the hydrophobic properties of the carbon nanotubes as grown, we used paint samples containing 0.3% by mass of both types of CNTs and observed an improvement in waterproofing through wettability and water absorption through immersion tests on the samples. Different solvents such as water, formaldehyde, and glycerin were used, and the results showed an increase in paint impermeability of 30% and 25% with the introduction of DWCNTs and MWCNTs, respectively. This indicates a promising, economically viable, and revolutionary method for applying nanotechnology in the polymer industry.

The fast-growing field of nanotheranostics is revolutionizing cancer treatment by allowing for precise diagnosis and targeted therapy at the cellular and molecular levels. These nanoscale platforms provide considerable benefits in oncology, including improved disease and therapy specificity, lower systemic toxicity, and real-time monitoring of therapeutic outcomes. However, nanoparticles' complicated interactions with biological systems, notably the immune system, present significant obstacles for clinical translation. While certain nanoparticles can elicit favorable anti-tumor immune responses, others cause immunotoxicity, including complement activation-related pseudoallergy (CARPA), cytokine storms, chronic inflammation, and organ damage. Traditional toxicity evaluation approaches are frequently time-consuming, expensive, and insufficient to capture these intricate nanoparticle-biological interactions. Artificial intelligence (AI) and machine learning (ML) have emerged as transformational solutions to these problems. This paper summarizes current achievements in nanotheranostics for cancer, delves into the causes of nanoparticle-induced immunotoxicity, and demonstrates how AI/ML may help anticipate and create safer nanoparticles. Integrating AI/ML with modern computational approaches allows for the detection of potentially dangerous nanoparticle qualities, guides the optimization of physicochemical features, and speeds up the development of immune-compatible nanotheranostics suited to individual patients. The combination of nanotechnology with AI/ML has the potential to completely realize the therapeutic promise of nanotheranostics while assuring patient safety in the age of precision medicine.